CO4970752A1 - Nuevos derivados de isatin y composiciones farmaceuticas conteniendo tales isatines - Google Patents
Nuevos derivados de isatin y composiciones farmaceuticas conteniendo tales isatinesInfo
- Publication number
- CO4970752A1 CO4970752A1 CO98043133A CO98043133A CO4970752A1 CO 4970752 A1 CO4970752 A1 CO 4970752A1 CO 98043133 A CO98043133 A CO 98043133A CO 98043133 A CO98043133 A CO 98043133A CO 4970752 A1 CO4970752 A1 CO 4970752A1
- Authority
- CO
- Colombia
- Prior art keywords
- isatin
- sulfonyl
- alkyl
- isatin5
- sulfo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Oncology (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Virology (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Abstract
Un compuesto de fórmula:en la que:R1 es hidrógeno o alquilo C1 -C4 ;R2 alquilo C1 -C10 , aril-alquilo C1 -C4 opcionalmente sustituido, heteroaril-alquilo C1 -C4 opcionalmente sustituido, cicloalquilo C3 -C7 opcionalmente sustituido, o R1 y R2 junto con el nitrógeno al que están unidos forman un anillo de 3 a 10 miembros que contiene opcionalmente un heteroátomo adicional seleccionado entre oxígeno,nitrógeno o azufre;R3 y R4 son alquilo C1 -C6 , hidrógeno, nitro o halógeno y R5 es alquilo C1 -C6 , hidrógeno, arilalquilo o heteroarilalquilo.El compuesto según la reivindicación 1, que es:(S)-(+)-5-[1-(2-Metoximetilpirrolidinil)sulfonil]- isatina DL-5-[1-(2-Hidroxietil)piperidinil)sulfonil]isatina(+/-)-5-[1-(3-Hidroximetil)piperidinil)sulfonil]isa-tina (S)-(+)-5-[1-(2-Hidroximetilpirrolidinil)sulfonil]-isatina(S)-(+)-5-[1-(2-Benciloxicarbonilpirrolidinil)sulfo-nil]isatina 5-[N-(N-Metil-2-hidroxietilamino)sulfonil]isatina5-[N-(N-Metil-2-(4-piridin)etilamino)sulfonil]isatina5-[N-(N´-Bencilpiperazin)sulfonil]isatina(R)-(-)-5-[1-(2-Metoximetilpirrolidinil)sulfonil]-isatina (S)-(+)-5-[1-(2-Metoxicarbonilpirrolidinil)sulfo-nil]isatina5-[N-(N-Metilanilino)sulfonil]isatina(S)-(+)-5-[1-(2-t-Butoxicarbonilpirrolidinil)sulfo-nil]isatina - 2 -
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5425597P | 1997-07-30 | 1997-07-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO4970752A1 true CO4970752A1 (es) | 2000-11-07 |
Family
ID=21989796
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO98043133A CO4970752A1 (es) | 1997-07-30 | 1998-07-29 | Nuevos derivados de isatin y composiciones farmaceuticas conteniendo tales isatines |
Country Status (10)
Country | Link |
---|---|
US (1) | US6403792B1 (es) |
EP (1) | EP1001933A4 (es) |
JP (1) | JP2001512100A (es) |
AR (1) | AR016384A1 (es) |
AU (1) | AU8763298A (es) |
CA (1) | CA2297757A1 (es) |
CO (1) | CO4970752A1 (es) |
IL (1) | IL132770A0 (es) |
WO (1) | WO1999006367A1 (es) |
ZA (1) | ZA986760B (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR016551A1 (es) * | 1997-07-30 | 2001-07-25 | Smithkline Beecham Corp | Derivados de 2-oxindol, composiciones farmaceuticas que los comprenden y el uso de los mismos para la manufactura de medicamentos |
US6747023B1 (en) * | 1998-08-11 | 2004-06-08 | Daiichi Pharmaceutical Co., Ltd. | Sulfonyl derivatives |
WO2001022966A1 (en) * | 1999-09-30 | 2001-04-05 | Smithkline Beecham Corporation | Caspases and apoptosis |
AU1898700A (en) * | 1999-12-20 | 2001-07-03 | Gho'st Holding B.V. | Pharmaceutical composition comprising a physiologically acceptable vanadium compound, salt or complex and NA+/H+ exchange inhibitor |
WO2001094311A1 (fr) * | 2000-06-08 | 2001-12-13 | Mitsubishi Pharma Corporation | Cytoprotecteurs |
SE0004780D0 (sv) | 2000-12-22 | 2000-12-22 | Jordanian Pharmaceutical Mfg & | Novel compunds |
AT413485B (de) * | 2001-04-09 | 2006-03-15 | Hemoteq Gmbh | Mit einem pharmazeutikum beschichteter stent |
CN1304374C (zh) * | 2002-04-30 | 2007-03-14 | 永进药品工业株式会社 | 可用做caspase-3抑制剂的喹啉衍生物及其制备方法和药用组合物 |
GB0327494D0 (en) * | 2003-11-26 | 2003-12-31 | Amersham Plc | Novel imaging agents |
US7256198B2 (en) | 2004-02-18 | 2007-08-14 | Wyeth | Pyrimidoindolones and methods for using same |
GB0411056D0 (en) | 2004-05-18 | 2004-06-23 | Novartis Ag | Organic compounds |
WO2009051244A1 (ja) * | 2007-10-18 | 2009-04-23 | Takeda Pharmaceutical Company Limited | 複素環化合物 |
KR20110066927A (ko) | 2008-09-05 | 2011-06-17 | 임페리얼 이노베이션스 리미티드 | 생체 내 영상화제로서 사용하기 위한 이사틴 유도체 |
DK2445502T4 (da) * | 2009-06-25 | 2022-11-28 | Alkermes Pharma Ireland Ltd | Heterocycliske forbindelser til behandling af neurologiske og psykologiske lidelser |
JP2013525438A (ja) | 2010-04-29 | 2013-06-20 | アメリカ合衆国 | ヒトピルビン酸キナーゼ活性剤 |
AU2012321345B2 (en) | 2011-10-03 | 2016-03-17 | The University Of Utah Research Foundation | Application of 5-HT6 receptor antagonists for the alleviation of cognitive deficits of down syndrome |
CN103183631B (zh) * | 2011-12-28 | 2016-08-24 | 天津市国际生物医药联合研究院 | 靛红-5-磺酰胺类衍生物及其在制备治疗非典型性肺炎的药物中的应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE715760C (de) * | 1938-12-02 | 1942-01-07 | Ig Farbenindustrie Ag | Verfahren zur Herstellung von Sulfonamiden der Indolreihe |
MC1357A1 (fr) | 1979-12-07 | 1981-08-10 | Hoffmann La Roche | Derives de 2,3-indoledione |
SE434638B (sv) | 1980-06-06 | 1984-08-06 | Lekemedelsfabriken Medica Ab | Nya terapeutiska verdefulla taurinderivat och deras framstellning |
US5164404A (en) * | 1991-03-15 | 1992-11-17 | Neurosearch A/S | Hydrazone derivatives and their use |
AU655643B2 (en) * | 1991-07-09 | 1995-01-05 | Neurosearch A/S | Novel isatineoxime derivatives, their preparation and use |
AU5772196A (en) | 1995-05-19 | 1996-11-29 | Chiroscience Limited | 3,4-disubstituted-phenylsulphonamides and their therapeutic use |
-
1998
- 1998-07-28 AR ARP980103699A patent/AR016384A1/es unknown
- 1998-07-29 ZA ZA986760A patent/ZA986760B/xx unknown
- 1998-07-29 CO CO98043133A patent/CO4970752A1/es unknown
- 1998-07-30 AU AU87632/98A patent/AU8763298A/en not_active Abandoned
- 1998-07-30 EP EP98939143A patent/EP1001933A4/en not_active Withdrawn
- 1998-07-30 WO PCT/US1998/015935 patent/WO1999006367A1/en not_active Application Discontinuation
- 1998-07-30 US US09/445,616 patent/US6403792B1/en not_active Expired - Fee Related
- 1998-07-30 IL IL13277098A patent/IL132770A0/xx unknown
- 1998-07-30 CA CA002297757A patent/CA2297757A1/en not_active Abandoned
- 1998-07-30 JP JP2000505126A patent/JP2001512100A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JP2001512100A (ja) | 2001-08-21 |
US6403792B1 (en) | 2002-06-11 |
ZA986760B (en) | 1999-02-01 |
EP1001933A4 (en) | 2002-11-06 |
IL132770A0 (en) | 2001-03-19 |
AR016384A1 (es) | 2001-07-04 |
EP1001933A1 (en) | 2000-05-24 |
CA2297757A1 (en) | 1999-02-11 |
AU8763298A (en) | 1999-02-22 |
WO1999006367A1 (en) | 1999-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO4970752A1 (es) | Nuevos derivados de isatin y composiciones farmaceuticas conteniendo tales isatines | |
AR011660A1 (es) | Uso de un compuesto neurotrofico de sulfonamida para efectuar una actividad neuronal en un animal | |
AR034253A1 (es) | Compuestos activadores de glucoquinasa que contienen hidantoina sustituida, un procedimiento para su preparacion, composiciones farmaceuticas, procedimientos para su preparacion, empleo de los mismos para la preparacion de medicamentos | |
ES2196806T3 (es) | Derivados de fenilurea y de feniltiourea. | |
ES2196772T3 (es) | Compuestos amino ciclicos. | |
HUP0401886A2 (hu) | Kemokin receptor aktivitás modulátorokként alkalmazható piperidinszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
DK1052254T3 (da) | Nitrogen-holdig heterocykliske derivater og medicin deraf | |
NO20052469L (no) | Inhibitorer av II-beta-hydroksysteroid-dehydrogenase type 1 og type 2. | |
MXPA02002720A (es) | Nuevos compuestos de alfa-aminoacido-sulfonilo, un proceso para su preparacion y composiciones farmaceuticas que los comprenden. | |
NO883487D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser. | |
NO915068D0 (no) | Fremgangsmaate for fremstilling av nye amino- og nitro-holdige tricykliske forbindelser | |
HUP9904622A2 (hu) | 1,4-Diszubsztituált piperidinek mint muszkarin antagonisták | |
DE69323090D1 (de) | 4-ALKOXY-2,6-DI-t-BUTYLPHENOLDERIVATE | |
AR042362A1 (es) | Derivados de 3h-quinazolin-4-ona, proceso de obtencion y composiciones farmaceuticas que los contienen | |
MX9202438A (es) | Esteroides 3-carboxi insaturados substituidos en la posicion 17 beta, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
AR006719A1 (es) | Derivados de bencilamina y formulacion farmaceutica que comprende a uno de dichos derivados. | |
AR004413A1 (es) | Compuestos de tiol que poseen actividad inhibitoria de metalopeptidasa; proceso para preparar dichos derivados; composiciones farmaceuticas que loscontienen | |
AR028606A1 (es) | Nuevos inhibidores de mmp-2/mmp-9 | |
PE20030611A1 (es) | Compuestos basicos lineales que tienen actividad antagonista de nk-2 y sus formulaciones | |
DE69612967T2 (de) | Optisch aktive thiazolidinonderivate | |
ES2183434T3 (es) | Derivados de cromano sustituidos con carboxilo utiles como agonistas de adrenoreceptores. | |
DE69312849T2 (de) | Mercapto-acetamid-derivate | |
AR022569A1 (es) | Derivados de fenilurea y feniltiourea | |
AR034516A1 (es) | Compuestos ciclicos de alfa amino-gama- hidroxiamidas, un procedimiento para su preparacion, y composiciones farmaceuticas que los contienen | |
HUP0105149A2 (hu) | Ciklusos guanidinszármazékok és peszticidkénti alkalmazásuk |